Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06073665 · ClinicalTrials.gov registry record · Phase 4
Dosing of LT4 in Older Individuals
A Phase 4 study of Hypothyroidism, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 228
- Enrollment target
- 1
- Study location
NCT06073665: Recruiting Phase 4 study of Hypothyroidism, sponsored by University of Pennsylvania.
NCT06073665 is a Phase 4 study of Hypothyroidism that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 228 participants, below the 803-participant average among 9 other Hypothyroidism trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06073665, a Phase 4 study of Hypothyroidism, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 228 participants
- Enrollment target
- 1
- Study location
Study Summary
Our overall goal is to determine the clinical consequences of allowing greater flexibility in LT4 dosing in older individuals who take LT4.
Primary Outcome
22 items, scored 0-100, higher scores indicate worse status
Conditions Studied
Interventions
- DRUG Levothyroxine Sodium
Study Locations (1)
Pennsylvania
- Penn Medicine, Smilow Translational Research Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 228 participants |
| Start Date | 2024-01-31 |
| Est. Completion | 2028-04-01 |
| Phase | Phase 4 |
What NCT06073665 shows while recruiting
NCT06073665 is an interventional study that assigns participants to a tested intervention. The registered 228 participants enrollment target is mid-sized for trials with a published cap, below the 803-participant average among 9 other Hypothyroidism trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Hypothyroidism appearing as the primary indexed condition, and to 1 intervention - of which Levothyroxine Sodium is the first listed.
NCT06073665 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06073665 about?
NCT06073665 is a clinical study titled "Dosing of LT4 in Older Individuals". Our overall goal is to determine the clinical consequences of allowing greater flexibility in LT4 dosing in older individuals who take LT4.
What is the current status of trial NCT06073665?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 228 participants. The study started on 2024-01-31. Estimated completion is 2028-04-01.
What conditions does trial NCT06073665 study?
This clinical trial studies the following conditions: Hypothyroidism.
What interventions are being tested in trial NCT06073665?
The interventions under investigation include: Levothyroxine Sodium (DRUG).
Who is sponsoring clinical trial NCT06073665?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06073665 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypothyroidism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06073665's enrollment target sits among peer trials
228 6th of 9 higher than 4 of 9 other Hypothyroidism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypothyroidism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
RECRUITING · Phase 2
-
Optimizing Care for Older Adults Through Thyroid Hormone Deprescribing
RECRUITING · NA
-
A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
RECRUITING · NA
-
Natural History of Thyroid Function Disorders
RECRUITING
-
Gluten Free Diet in Hashimoto's Hypothyroidism
RECRUITING · NA
-
Novel Approaches to the Treatment of Hypothyroidism
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05107908 · 228 participants · NA
Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity
- NCT05547698 · 228 participants · NA
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
- NCT05630963 · 228 participants
Beyond Monoamines: The Role of the Nociceptin/Orphanin FQ Receptor in Major Depression
- NCT06116422 · 228 participants · NA
Nutrition and Obesity in Under-Represented Populations: Food Insecurity Research to Advance Science and Improve Health
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI